Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

2.

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

3.

A video animation guide to assist young people who are fatigued from cancer.

4.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

5.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot